Drug Type ASO |
Synonyms Scn2a ASO - RogCon Biosciences, RC 222, RC-222 |
Target |
Action blockers |
Mechanism Nav1.2 blockers(Sodium channel protein type II alpha subunit blockers) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
License Organization |
Drug Highest PhasePendingPreclinical |
First Approval Date- |
Regulation- |

| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Epilepsy | Preclinical | United States | 14 Dec 2018 | |
| Epilepsy | Preclinical | United States | 14 Dec 2018 | |
| Epilepsy | Preclinical | United States | 14 Dec 2018 |





